Modulation of immune responses with transcutaneously deliverable adjuvants
- 23 June 2004
- Vol. 22 (19) , 2385-2390
- https://doi.org/10.1016/j.vaccine.2003.11.063
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mucosal Immunization with Inactivated Human Immunodeficiency Virus plus CpG Oligodeoxynucleotides Induces Genital Immune Responses and Protection against Intravaginal ChallengeThe Journal of Infectious Diseases, 2002
- The LTR72 Mutant of Heat-Labile Enterotoxin ofEscherichia coliEnhances the Ability of Peptide Antigens To Elicit CD4+T Cells and Secrete Gamma Interferon after Coapplication onto Bare SkinInfection and Immunity, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG‐containing oligodeoxynucleotide and effective priming of influenza virus‐specific CD4+ T cellsImmunology, 2002
- Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosisEuropean Journal of Immunology, 2001
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Immunity at the surface: Homeostatic mechanisms of the skin immune systemLife Sciences, 1996
- Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN?-treated cultured keratinocytesArchives of Dermatological Research, 1995
- Langerhans Cells Phagocytose Vaginal Epithelial Cells Undergoing Apoptosis during the Murine Estrous Cycle1Biology of Reproduction, 1991
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989